Pharmaceutical Industry News
Analysis of regulation, quality, innovation, market and trends in Europe and Latin America.
Anvisa approves regulations for biosimilars
New standard eases requirements and simplifies product development, promoting a transparent regulatory environment....
Protocole the Import License after NCM reclassification
Anvisa updates procedures for licensing imports, providing new guidelines for cases of NCM reclassification....
Report approved to revise regulations on imported goods
The Board of Directors has approved the Regulatory Impact Report to revise the regulations on imported goods....
SP approves cannabidiol and tetrahydrocannabinol protocol
Resolution SS 107/05/24 directs doctors to prescribe cannabidiol and tetrahydrocannabinol for specific syndromes....
Anvisa to use external analysis to register medical devices
The measure speeds up the evaluation of products already approved by foreign authorities, reinforcing regulatory confidence....
Decree-Law implements EU regulation on medical devices
A new regulation implements EU guidelines for medical devices, setting standards for operators and market monitoring....
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.